NDAINJECTIONINJECTABLE
Approved
May 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
6/8 — Strong
Drug Shortage Active
DEPO-MEDROL is currently in shortage. Reason: Available. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
DEPO-MEDROL (methylprednisolone acetate) by Pfizer is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids. Approved for dermatomyositis, polymyositis, systemic lupus erythematosus and 13 more indications. First approved in 1959.
Drug data last refreshed 7h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DEPO-MEDROL is a glucocorticoid steroid injection containing methylprednisolone acetate, used to suppress inflammation and modify immune response across multiple organ systems. It treats autoimmune and inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus, asthma, ulcerative colitis, and severe allergic reactions. The drug works by blocking inflammatory mediators and suppressing immune cell activation.
$21KPart D
LOE ApproachingDeclining
Mature product with minimal growth trajectory and stable but small commercial team focused on maintenance rather than expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt retaining properties, are used in replacement therapy in adrenocortical deficiency states. Their synthetic…
Indications (16)
Worked on DEPO-MEDROL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.